Latest Global Markets News

Web Travel Group signals strong momentum heading into FY26, projecting record EBITDA and a robust $3.1 billion in first-half Total Transaction Value despite geopolitical headwinds.

Goodman Group has announced a total distribution of 15 cents per stapled security for the year ended 30 June 2025, combining dividends from its Hong Kong logistics arm and its Australian industrial trust.

Genetic Signatures reported a 63% revenue increase to $15.9 million in FY25, alongside a 28% reduction in underlying losses and a strategic shift in its automated diagnostics platform development.

LTR Pharma’s SPONTAN nasal spray has achieved unanimous patient satisfaction in treating erectile dysfunction after prostate surgery, signaling a promising shift in therapy preferences.

Argo Global Listed Infrastructure Ltd reports a striking jump in full-year profit to $52.2 million and declares a record fully franked dividend, highlighting the resilience of its global infrastructure portfolio amid volatile markets.

Argo Global Listed Infrastructure Limited reported a remarkable 307% increase in profit for the year ended June 2025, alongside a 269% jump in investment income, underpinning a higher fully franked dividend.

Infomedia Ltd reported solid FY25 results with revenue up 4% to $146.5 million and net profit rising 32%, driven by key product growth and a strategic AI acquisition. The company also recommended shareholder approval of a premium takeover offer from TPG Capital.

Navigator Global Investments has delivered a record financial performance in FY25, with Adjusted EBITDA rising 26% and net profit after tax soaring 80%, underpinned by strong asset growth and strategic board changes.

Sun Silver Limited reports significant antimony mineralisation in historic drillhole MR127 at its Maverick Springs Project, reinforcing plans for a maiden antimony resource alongside its established silver-gold system.

Axel REE Limited has announced a maiden inferred gallium mineral resource of 100 million tonnes at its Caladão Project in Brazil, marking a significant milestone in critical minerals exploration amid global supply constraints.

INOVIQ Limited reported a $6.9 million net loss for FY25 while making significant strides in its exosome-based cancer diagnostics and therapeutics pipeline, including a breakthrough ovarian cancer screening test and promising CAR-exosome therapy results.

LTR Pharma has announced that its erectile dysfunction treatment SPONTAN now boasts an 18-month shelf life, surpassing commercial standards and paving the way for international market growth.